2 Biotech Stocks Making Headlines

PRQR is attracting options bulls amid today's soaring price action

Deputy Editor
Dec 22, 2022 at 10:42 AM
facebook X logo linkedin

Two biotech stocks are in the spotlight today, ProQR Therapeutics NV (NASDAQ:PRQR) and Mirati Therapeutics Inc (NASDAQ:MRTX), with the former attracting plenty of options activity. Below we'll take a closer look at what catalysts are behind today's price action for the equities.

ProQR Therapeutics Stock Skyrocketing

The shares of ProQR Therapeutics are soaring, up 69% at $2.79 at last glance, after news that Eli Lilly (LLY) is expanding its partnership with the company for RNA-editing-based genetic medicines. This pop has PRQR at its highest level since its February bear gap, which occurred after its rare eye disease drug failed in a mid- to late-stage trial and sent the stock spiraling into penny stock territory. The equity still has a long way to go before it is fully recovered, however. Year-to-date, the security is down 63%. 

PRQR's typically quiet options pits are a bustle with bullish activity. So far today, 4,255 calls have been exchanged, which is 223 times the average intraday amount. The January 2023 5-strike call is the most popular, followed by the 2.50-strike call in the same monthly series. 

Mirati Therapeutics Receives FDA Praise

Mirati Therapeutics stock reversed its premarket surge, trading flat at $41.31 at last glance. The U.S. Food & Drug Administration (FDA) designated its colorectal cancer treatment as a "breakthrough therapy," which fast tracks the approval process. 

On the charts, MRTX has been struggling since its early-December slide, down 71.6% year-to-date. The $40 level has swooped in as support, though longer term, pressure at its 320-day moving average kept a lid on the stock's November rally. 


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI